A Wayne State University School of Medicine researcher is being recognized for his record of prolific scientific publication and the high impact of that work.

Avraham Raz, Ph.D., the Paul Zuckerman Professor of Oncology and Pathology, an internationally recognized leader in the field of cancer metastasis, has been named an inaugural Highly Ranked Scholar by ScholarGPS™. The recognition comes as his scholarly contributions place him in the top .05% of all scholars worldwide.

ScholarGPS is a continually updated worldwide compilation of metadata of more than 200 million journal papers, books, conference papers and patents of 30 million scholars.

“I am trying my best to be as good as I can,” Dr. Raz said.

The organization listed Dr. Raz 24th in the area of metastasis and 30th in motility as one of its lifetime highly ranked scholars.

Dr. Raz is best known for his pioneering work on galectins research in cancer, identifying the first “normal” chimeric gene product (galectin 3), and characterization of a novel cancer motility factor and its receptor that resulted in a new biological concept of “moonlighting proteins.” His groundbreaking discoveries have opened innovative strategies and avenues relevant to the understanding of cancer cell trafficking and signaling governing metastatic processes. His work has resulted in more than 60 clinical trials, and he has received the National Cancer Institute’s Merit Award.

Per Google Scholar, the president-elect of the School of Medicine’s Executive Committee has an h-index of 102, with 32,327 citations.